Millions more OTC products recalled by J&J

November 29, 2010
Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls

Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …

Pharma unprepared for personalised oncology

November 29, 2010
Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …

Pfizer headquarters

Pfizer submits Gaucher drug to EMA

November 29, 2010
Sales and Marketing Cerezyme, EMA, Gaucher disease, Genzyme, Pfizer, Protalix BioTherapeutics, Shire, Vpriv, taliglucerase alfa

Pfizer and partner Protalix BioTherapeutics have submitted a marketing application to European regulator the EMA for their Gaucher disease candidate …

Doctors.net.uk

Doctor’s networks – an emerging engagement channel

November 29, 2010
Medical Communications, Sales and Marketing Len Starnes, PatientsLikeMe, doctors' social networks, social media, social networking

The last four years have seen an extraordinary growth in physicians’ social networks and a rapid increase in levels of …

NHS Choices erectile dysfunction

Digital Pharma: NHS Facebook tracking under fire

November 26, 2010
Medical Communications Digital Pharma blog, Facebook, online privacy, patient information

The government has been criticised for failing to protect patient confidentiality after it was revealed it allows Facebook to collect …

Novartis’ Afinitor (everolimus)

Novartis fails to sway NICE with Afinitor deal

November 26, 2010
Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis, advanced renal cell carcinoma, everolimus

Novartis has failed to convince NICE that its revised patient access scheme for Afinitor would make the kidney cancer drug …

NHS Atlas shows health outcomes variation across England’s PCTs

November 26, 2010
Sales and Marketing NHS, NHS Atlas, NHS reform, PCTs, Primary Care Trusts, healthcare variation, statin prescribing

A new tool will allow observers to compare at a glance what 152 Primary Care Trusts (PCTs) in England spend …

Interlace expands editorial and client services teams

November 26, 2010
Medical Communications Becky Butlin, Interlace, Isobel Strang, Julianna Solomons, Raj Jangra, Sandra Boswell, Wells Healthcare, appointment, medical communications

Interlace Global Group has appointed eight new members of staff to its editorial and client services teams after winning five …

Complete Digital appoints Emma D’Arcy

November 26, 2010
Business Services, Medical Communications Complete Digital, Emma D'Arcy, McCann Healthcare, appointment, medical communications, physician relationships, social media

Emma D’Arcy has joined McCann Healthcare’s Complete Digital group as a senior consultant. Emma has worked with pharmaceutical companies, the …

Pharma outsourcing recovering, but tough times are ahead

November 26, 2010
Manufacturing and Production, Research and Development AAPS, American Association of Pharmaceutical Sciences, Jim Miller, Pharmsource, contract manufacturing, contract research, pharma outsourcing

There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …

Contract research news in brief

November 26, 2010
Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research

Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …

abpi_sam_ogden

Roche’s Sam Ogden joins the ABPI

November 25, 2010
Medical Communications, Sales and Marketing ABPI, Sam Ogden, appointment, medical communications, sales and marketing

The ABPI has appointed Sam Ogden as membership engagement account director. She is currently head of in-field effectiveness at Roche …

European Parliament

Europe tightens patient information proposals

November 25, 2010
Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information

European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …

Gilead’s pill shows promise in HIV prevention

November 25, 2010
Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010
Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …

Tarceva tablet

Roche set to challenge NICE Tarceva decision

November 25, 2010
Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer

NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …

The renal cell carcinoma market: Votrient to challenge Sutent’s lead

November 25, 2010
Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma

After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …

Dr Reddy's Hyderabad, India

GSK sells antibiotics assets to Dr Reddy’s

November 24, 2010
Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK

Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …

Varnish chemical migrates into medicine bottles, says study

November 24, 2010
Manufacturing and Production AAPS, HDPE, chemical migration, varnish

A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …

Brain cancer vaccine to move into phase III

November 24, 2010
Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma

Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …

The Gateway to Local Adoption Series

Latest content